According to the Zhitong Finance App, Pilot Pharmaceutical Biotechnology (00399.HK) announced its annual results for the year ended March 31, 2025, with revenue of HK$2,091 million, a year-on-year decrease of 68.3%; loss attributable to company owners was HK$346 million, profit of HK$103 million for the same period last year; basic loss per share was HK$20.01 cents.

According to the Zhitong Finance App, Pilot Pharmaceutical Biotechnology (00399.HK) announced its annual results for the year ended March 31, 2025, with revenue of HK$2,091 million, a year-on-year decrease of 68.3%; loss attributable to company owners was HK$346 million, profit of HK$103 million for the same period last year; basic loss per share was HK$20.01 cents.